IU Cancer Center receives new and renewed ACS funding for research, education programs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Indiana University Melvin and Bren Simon Comprehensive Cancer Center received new and renewed funding from the American Cancer Society to support research and education programs.

IU cancer researchers are currently receiving more than $6 million in multi-year ACS funding across the Indianapolis and Bloomington campuses. 

New this year, the cancer center received a $660,000 grant as one of eight inaugural sites for the American Cancer Society Post-Baccalaureate Diversity in Cancer Research Education Program. The two-year cancer research experience is designed for students of underrepresented background or disadvantaged populations who have recently been awarded their bachelor’s degree and intend to pursue clinical or research careers in cancer.

The post-baccalaureate program prepares participants for competitive MD and PhD programs through hands-on research experiences and includes a $37,565 yearly stipend, a housing stipend, and health insurance during the two-year program. Applications are now being accepted. More information can be found here.

“The IU Simon Comprehensive Cancer Center is fully committed to increasing the diversity of our students and faculty. This will result in more diverse cancer researchers and clinicians to drive future cancer treatments and discoveries,” Mark Kelley, the Betty and Earl Herr Professor of Pediatric Oncology Research at IU School of Medicine and the associate director of basic science research at the cancer center, said in a statement. Kelley serves as the lead cancer center faculty directing the grant.

The ACS also has renewed the cancer center’s ACS Institutional Research Grant to provide pilot project funding to assist early-career cancer investigators, giving them the opportunity to establish their research program and explore innovative ideas. The IRG has been continuously funded by the ACS since 1986 and will provide $360,000 over the next three years.

Now in its second year at the cancer center, the ACS also provides funding for an education program designed to build the pipeline for diversity in cancer research.

The Diversity in Cancer Research internship program aims to increase the number of undergraduate students from underrepresented populations pursuing clinical and research careers in cancer. It is supported via a supplement to the ACS IRG, and directed at the cancer center by Tim Corson and Shannon Hawkins The IU Simon Comprehensive Cancer Center was one of only 12 universities to implement this American Cancer Society internship program last year, which is funded through 2024.

Additionally, six investigators are funded with $4.7 million in multi-year Research Scholar Grants, which support independent, self-directed researchers and clinician scientists. These grants are funding research in ovarian and breast cancers, DNA replication errors in cancer, among other topics.

Current RSG recipients are Lata Balakrishnan, Anirban K. Mitra, Sumegha Mitra, Hengyao Niu, Jenifer Prosperi, and Chi Zhang.

Table of Contents

YOU MAY BE INTERESTED IN

Fifty-four years ago, in his State of the Union Message in January 1971, President Nixon proposed a visionary and vigorous new challenge.  He said “The time has come in America when the same kind of concentrated effort that split the atom and took man to the moon” should be applied to finding a cure for cancer.  He followed up by requesting an appropriation of $100 million, and the promise to ask for whatever additional funds could be effectively used.  
Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men. 

In a new article on the Cancer History Project, the American Cancer Society profiles three ACS-funded Nobel laureates:  David Baker, PhD2024 Nobel PrizeChemistry Victor Ambrose, PhD 2024 Nobel Prize Physiology or Medicine Gary Ruvkun, PhD2024 Nobel Prize Physiology or Medicine They join a cohort of 50 other ACS-funded Nobel laureates.  “The American Cancer Society’s legacy, with 53 Nobel...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login